ArticleCancer biology & therapy2015

A peptide nucleic acid targeting nuclear RAD51 sensitizes multiple myeloma cells to melphalan treatment.

David Abasiwani Alagpulinsa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.